Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04312633 · ClinicalTrials.gov registry record

Clinical Utility of WATS3D: A 5-Year Prospective Study

A clinical trial of Barrett Esophagus and Gastro Esophageal Reflux, sponsored by CDx Diagnostics.

Recruiting
Registry status
90,000
Enrollment target
1
Study location

NCT04312633 is a study of Barrett Esophagus and Gastro Esophageal Reflux that is actively recruiting participants, run by CDx Diagnostics. The registered enrollment target is 90,000 participants, above the 753-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (11852% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04312633, a study of Barrett Esophagus and Gastro Esophageal Reflux, is actively recruiting participants, sponsored by CDx Diagnostics.

RECRUITING
Registry status
90,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to create a registry (collect data and keep it in a research database) to learn more about two methods of taking small tissue samples from your esophagus (the esophagus is the tube that carries food and liquid from your mouth to your stomach). The two methods of sampling are: 1) Using forceps that take biopsies (small tissue samples) from your esophagus, and 2) Using a brush that also takes biopsies from your esophagus.

Study Locations (1)

New York

  • NYU Langone Ambulatory Care - Bethpage

Trial Details

FieldValue
Enrollment Target 90,000 participants
Start Date 2020-04-01
Est. Completion 2027-11-01

Sponsor

CDx Diagnostics

4 total trials

What the Registry Record Tells You About NCT04312633

The ClinicalTrials.gov registry entry for NCT04312633 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 90,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 753-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (11852% higher). The listed sponsor is CDx Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 0 interventions.

NCT04312633 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04312633 about?

NCT04312633 is a clinical study titled "Clinical Utility of WATS3D: A 5-Year Prospective Study". The purpose of this study is to create a registry (collect data and keep it in a research database) to learn more about two methods of taking small tissue samples from your esophagus (the esophagus is the tube that carries food and liquid from your mouth to your stomach). The two methods of sampling...

What is the current status of trial NCT04312633?

This trial is currently recruiting. The enrollment target is 90,000 participants. The study started on 2020-04-01. Estimated completion is 2027-11-01.

What conditions does trial NCT04312633 study?

This clinical trial studies the following conditions: Barrett Esophagus, Gastro Esophageal Reflux, Esophageal Diseases, Esophageal Dysplasia.

Who is sponsoring clinical trial NCT04312633?

This trial is sponsored by CDx Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04312633 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Barrett Esophagus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.